G1 Therapeutics Inc (NASDAQ:GTHX)
| 2.61 Delayed Data As of Jun 02 |  +0.08 / +3.16%Today’s Change | 2.38 Today|||52-Week Range 17.49 | -51.93% Year-to-Date |
Latest GTHX News | Press Releases
No recent news for G1 Therapeutics Inc.
Today’s Trading
| Previous close | 2.53 |
| Today’s open | 2.58 |
| Day’s range | 2.56 - 2.65 |
| Volume | 24,071 |
| Average volume (3 months) | 1,115,232 |
| Market cap | $135.4M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +4.37% |
| Earnings growth (this year) | +55.13% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +62.98% |
| P/E ratio | NM |
| Price/Sales | 4.62 |
| Price/Book | 1.96 |
Competitors
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $51.3M |
| Annual profit (last year) | -$147.6M |
| Net profit margin | -287.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Research Triangle Park, North Carolina |
Forecasts
